Variant report

Variant	nsv9729
Chromosome Location	chr19:41337805-41394407
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:667)
CpG islands
(count:733)
Chromatin interactive
region (count:5)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:667 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41337675-41338160	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
3	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
4	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
5	ATF1	chr19:41339642-41339915	K562	blood:	n/a	n/a
6	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
7	ATF3	chr19:41339727-41339986	K562	blood:	n/a	n/a
8	ATF3	chr19:41337642-41338304	A549	lung:	n/a	n/a
9	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
10	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
11	ATF3	chr19:41339265-41339474	K562	blood:	n/a	n/a
12	BCL3	chr19:41337271-41338291	A549	lung:	n/a	n/a
13	BCL3	chr19:41337399-41338400	A549	lung:	n/a	n/a
14	BHLHE40	chr19:41337704-41338087	A549	lung:	n/a	chr19:41337896-41337917
15	BHLHE40	chr19:41337685-41338115	K562	blood:	n/a	chr19:41337896-41337917
16	BHLHE40	chr19:41337595-41338254	HepG2	liver:	n/a	chr19:41337896-41337917
17	BHLHE40	chr19:41337763-41338048	HepG2	liver:	n/a	chr19:41337896-41337917
18	BHLHE40	chr19:41339267-41339464	K562	blood:	n/a	n/a
19	BHLHE40	chr19:41337782-41338177	HepG2	liver:	n/a	chr19:41337896-41337917
20	BHLHE40	chr19:41339813-41339844	K562	blood:	n/a	n/a
21	BRCA1	chr19:41337806-41338121	Hela-S3	cervix:	n/a	n/a
22	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
23	CBX3	chr19:41347938-41348304	K562	blood:	n/a	n/a
24	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
25	CBX3	chr19:41349182-41350047	K562	blood:	n/a	n/a
26	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
27	CBX3	chr19:41339143-41339980	K562	blood:	n/a	n/a
28	CBX3	chr19:41347915-41348277	K562	blood:	n/a	n/a
29	CBX3	chr19:41337733-41338384	K562	blood:	n/a	n/a
30	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
31	CCNT2	chr19:41339675-41339875	K562	blood:	n/a	n/a
32	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
33	CEBPB	chr19:41337643-41338329	HCT-116	colon:	n/a	n/a
34	CEBPB	chr19:41337683-41338182	HCT-116	colon:	n/a	n/a
35	CEBPB	chr19:41337501-41338182	HepG2	liver:	n/a	n/a
36	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
37	CEBPB	chr19:41337684-41338241	A549	lung:	n/a	n/a
38	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
39	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
40	CEBPB	chr19:41337708-41338253	MCF-7	breast:	n/a	n/a
41	CEBPB	chr19:41337501-41338297	Hela-S3	cervix:	n/a	n/a
42	CEBPB	chr19:41337837-41338187	HepG2	liver:	n/a	n/a
43	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
44	CEBPB	chr19:41343011-41343287	HepG2	liver:	n/a	chr19:41343121-41343132
45	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr19:41339359-41340046	K562	blood:	n/a	chr19:41339540-41339548
47	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
48	CEBPB	chr19:41343058-41343265	A549	lung:	n/a	chr19:41343121-41343132
49	CEBPB	chr19:41342862-41343338	A549	lung:	n/a	chr19:41343121-41343132
50	CEBPB	chr19:41337826-41338039	HepG2	liver:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41385865-41385915	HEEpiC	esophagus:	n/a
2	chr19:41385865-41385915	HEEpiC	esophagus:	n/a
3	chr19:41386441-41386491	LNCaP	prostate:	n/a
4	chr19:41385865-41385915	SK-N-SH_RA	brain:	n/a
5	chr19:41351924-41351974	U87	brain:	n/a
6	chr19:41351924-41351974	BJ	skin:	n/a
7	chr19:41386441-41386491	HCF	heart:	n/a
8	chr19:41354142-41354192	HEK293	kidney:	embryo
9	chr19:41385865-41385915	AG09309	skin:	n/a
10	chr19:41386507-41386557	HIPEpiC	eye:	n/a
11	chr19:41386441-41386491	NH-A	brain:	n/a
12	chr19:41354682-41354732	SKMC	muscle:	n/a
13	chr19:41388384-41388434	RPTEC	kidney:	n/a
14	chr19:41386441-41386491	SK-N-SH	brain:	n/a
15	chr19:41388232-41388282	HCF	heart:	n/a
16	chr19:41388384-41388434	SAEC	small airway:	n/a
17	chr19:41388232-41388282	HNPCEpiC	eye:	n/a
18	chr19:41354682-41354732	SAEC	small airway:	n/a
19	chr19:41355973-41356023	AG04450	lung:	fetal
20	chr19:41389684-41389734	GM06990	blood:	n/a
21	chr19:41385865-41385915	GM12891	blood:	n/a
22	chr19:41355973-41356023	AoSMC	blood vessel:	n/a
23	chr19:41389684-41389734	HepG2	liver:	n/a
24	chr19:41354553-41354603	IMR90	lung:	fetal
25	chr19:41354142-41354192	ProgFib	skin:	n/a
26	chr19:41355973-41356023	PANC-1	pancreas:	n/a
27	chr19:41354682-41354732	MCF-7	breast:	n/a
28	chr19:41354553-41354603	MCF10A-Er-Src	breast:	n/a
29	chr19:41386507-41386557	HL-60	blood:	n/a
30	chr19:41388232-41388282	LNCaP	prostate:	n/a
31	chr19:41355973-41356023	Caco-2	colon:	n/a
32	chr19:41385865-41385915	A549	lung:	n/a
33	chr19:41354553-41354603	GM12891	blood:	n/a
34	chr19:41389684-41389734	SAEC	small airway:	n/a
35	chr19:41386441-41386491	SK-N-SH_RA	brain:	n/a
36	chr19:41383654-41383704	PrEC	prostate:	n/a
37	chr19:41354682-41354732	GM19239	blood:	n/a
38	chr19:41354142-41354192	PANC-1	pancreas:	n/a
39	chr19:41355973-41356023	HRPEpiC	eye:	n/a
40	chr19:41388384-41388434	AG04450	lung:	fetal
41	chr19:41385865-41385915	CMK	blood:	n/a
42	chr19:41389684-41389734	GM12891	blood:	n/a
43	chr19:41383654-41383704	HCT-116	colon:	n/a
44	chr19:41388384-41388434	LNCaP	prostate:	n/a
45	chr19:41354142-41354192	HepG2	liver:	n/a
46	chr19:41354553-41354603	HPAEpiC	pulmonary alveolar:	n/a
47	chr19:41354553-41354603	HMEC	breast:	n/a
48	chr19:41385865-41385915	BJ	skin:	n/a
49	chr19:41354553-41354603	HRPEpiC	eye:	n/a
50	chr19:41354553-41354603	HCF	heart:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
2	chr19:41168873..41171001-chr19:41337568..41339858,2	MCF-7	breast:
3	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
4	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:
5	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2A6-1	chr19:41342991-41343115	ENSG00000269843.1

No data

Variant related genes	Relation type
ENSG00000269843	TF binding region
CYP2G1P	TF binding region
CYP2A6	TF binding region
CYP2A7	TF binding region
ENSG00000269843	CpG island
CYP2G1P	CpG island
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000262246	chromatin interactions
ENSG00000105245	chromatin interactions
ENSG00000103423	chromatin interactions

Extended variants
information (count: 3001 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:3001 , 50 per page) page: 1 2 3 4 5 6 7 ... 61

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs193278068	chr19:41337820-41337821	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs114680880	chr19:41337830-41337831	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs185429902	chr19:41337836-41337837	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs190266468	chr19:41337843-41337844	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs377113772	chr19:41337866-41337867	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs191878085	chr19:41337884-41337885	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs184315813	chr19:41337893-41337894	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs11879413	chr19:41337923-41337924	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs545210088	chr19:41337976-41337977	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs188698044	chr19:41338047-41338048	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs572131357	chr19:41338048-41338049	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs542339628	chr19:41338071-41338072	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs560981855	chr19:41338086-41338087	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs8107294	chr19:41338183-41338184	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs3852867	chr19:41338202-41338203	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs565189625	chr19:41338226-41338227	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs181137433	chr19:41338235-41338236	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs141028140	chr19:41338256-41338257	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs149829169	chr19:41338293-41338294	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs3852868	chr19:41338372-41338373	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs58888527	chr19:41338373-41338374	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs11429581	chr19:41338445-41338446	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs71173686	chr19:41338462-41338463	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs185179312	chr19:41338513-41338514	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs3865453	chr19:41338556-41338557	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs533110280	chr19:41338583-41338584	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs2431409	chr19:41338611-41338612	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs375733094	chr19:41338612-41338613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs189058837	chr19:41338621-41338622	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs182447710	chr19:41338628-41338629	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs186994923	chr19:41338631-41338632	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs571626767	chr19:41338653-41338654	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs66889044	chr19:41338712-41338713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs554376535	chr19:41338713-41338714	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs28744583	chr19:41338732-41338733	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs11667982	chr19:41338761-41338762	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs2258623	chr19:41338825-41338826	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs2258314	chr19:41338835-41338836	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs143200968	chr19:41338847-41338848	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs2258380	chr19:41338988-41338989	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs543459052	chr19:41339052-41339053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs546635566	chr19:41339142-41339143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs374582198	chr19:41339146-41339147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs564847297	chr19:41339202-41339203	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs577238776	chr19:41339205-41339206	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs148279271	chr19:41339220-41339221	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs559545069	chr19:41339230-41339231	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs539155316	chr19:41339237-41339238	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs55716646	chr19:41339238-41339239	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs548323056	chr19:41339252-41339253	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:542 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41324800-41339200	Weak transcription	Brain Germinal Matrix	brain
2	chr19:41326000-41339800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
3	chr19:41330000-41339800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr19:41330200-41349400	Weak transcription	Right Ventricle	heart
5	chr19:41331600-41339800	Weak transcription	Fetal Lung	lung
6	chr19:41333400-41338000	Weak transcription	Duodenum Mucosa	Duodenum
7	chr19:41333400-41338400	Weak transcription	Primary T cells from cord blood	blood
8	chr19:41333400-41339200	Weak transcription	Brain Angular Gyrus	brain
9	chr19:41333400-41339200	Weak transcription	Brain Substantia Nigra	brain
10	chr19:41333600-41339000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr19:41333600-41339200	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
12	chr19:41333600-41339800	Weak transcription	Brain Inferior Temporal Lobe	brain
13	chr19:41333600-41349400	Weak transcription	Left Ventricle	heart
14	chr19:41333800-41339200	Weak transcription	Primary T helper cells fromperipheralblood	blood
15	chr19:41334000-41338000	Weak transcription	Fetal Stomach	stomach
16	chr19:41334000-41338200	Weak transcription	Brain Cingulate Gyrus	brain
17	chr19:41334000-41338600	Weak transcription	Skeletal Muscle Female	skeletal muscle
18	chr19:41334000-41339200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
19	chr19:41334000-41339200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
20	chr19:41334000-41339200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
21	chr19:41334000-41339200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
22	chr19:41334000-41339800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr19:41334200-41339000	Weak transcription	Primary T cells fromperipheralblood	blood
24	chr19:41334200-41339200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr19:41334200-41339200	Weak transcription	Primary T helper cells PMA-I stimulated	--
26	chr19:41336200-41339000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
27	chr19:41336400-41340200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr19:41336400-41340800	Enhancers	Fetal Intestine Large	intestine
29	chr19:41336600-41339400	Enhancers	Ovary	ovary
30	chr19:41336600-41340800	Enhancers	Fetal Intestine Small	intestine
31	chr19:41337000-41339600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr19:41337200-41338600	Enhancers	Muscle Satellite Cultured Cells	--
33	chr19:41337200-41338600	Enhancers	A549	lung
34	chr19:41337200-41338600	Enhancers	HSMMtube	muscle
35	chr19:41337200-41338800	Enhancers	Hela-S3	cervix
36	chr19:41337200-41338800	Enhancers	HepG2	liver
37	chr19:41337200-41339000	Enhancers	NHDF-Ad	bronchial
38	chr19:41337200-41339600	Enhancers	Rectal Mucosa Donor 29	rectum
39	chr19:41337200-41340000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr19:41337200-41340000	Enhancers	Adipose Nuclei	Adipose
41	chr19:41337200-41340000	Enhancers	Liver	Liver
42	chr19:41337200-41340000	Enhancers	Osteobl	bone
43	chr19:41337200-41340200	Enhancers	Placenta	Placenta
44	chr19:41337400-41338200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
45	chr19:41337400-41338200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
46	chr19:41337400-41338400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr19:41337400-41338400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr19:41337400-41338400	Enhancers	NHLF	lung
49	chr19:41337400-41338600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr19:41337400-41338600	Enhancers	Pancreas	Pancrea

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links